Journal Menu
- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Journal of Nanomaterials
Volume 2013 (2013), Article ID 629681, 12 pages
http://dx.doi.org/10.1155/2013/629681
Review Article
Nanomedicine in Action: An Overview of Cancer Nanomedicine on the Market and in Clinical Trials
Nordion Inc., 447 March Road, Ottawa, ON, K2K 1X8, Canada
Received 22 October 2012; Accepted 9 November 2012
Academic Editor: Haiyan Li
Copyright © 2013 Ruibing Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
How to Cite this Article
Ruibing Wang, Paul S. Billone, and Wayne M. Mullett, “Nanomedicine in Action: An Overview of Cancer Nanomedicine on the Market and in Clinical Trials,” Journal of Nanomaterials, vol. 2013, Article ID 629681, 12 pages, 2013. doi:10.1155/2013/629681